Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

甲状腺癌 肿瘤科 医学 内科学 癌症 甲状腺癌 原发性癌症 甲状腺 数据库 计算机科学
作者
Jianhua Feng,Caixiu Wu,Fei Shen,Wen-song Cai,Bo Xu
出处
期刊:The Journal of Clinical Endocrinology and Metabolism [The Endocrine Society]
被引量:1
标识
DOI:10.1210/clinem/dgae501
摘要

Abstract Context Adult cancer survivors are at a heightened risk for secondary primary differentiated thyroid carcinoma (2-DTC). The characteristics and outcomes of 2-DTC remain poorly understood. Objective We aimed to explore the characteristics and outcomes of 2-DTC. Methods We retrospectively analyzed data from the Surveillance, Epidemiology, and End Results (SEER) database (2000-2017). 2-DTC was divided into 25 subgroups based on prior primary malignancies (PPMs). Baseline characteristics were compared using the chi-square test. Multivariable logistic analysis was used to identified if PPMs were associated with aggressive DTC characteristics. DTC-specific and cancer-specific mortality were analyzed using a univariable and multivariable competing risk regression model. Results There were 138 555 1-DTC and 9253 2-DTC patients identified. 2-DTC patients were predominantly older, male, and White compared to first primary DTC (1-DTC) (all P < .05). In multivariable logistic regression analysis, only 4 types of PPMs were associated with higher rates of DTC aggressive characteristics, while 19 types exhibited lower rates (all P < .05). In multivariable competing risk analysis, 2-DTC showed no mortality risk in stages I (SHR: 1.16; 95% CI, 0.65-2.07) and II (SHR: 0.67; 95% CI, 0.45-1.01), but a protective role in stages III (SHR: 0.47; 95% CI, 0.27-0.83) and IV (SHR: 0.72; 95% CI, 0.52-0.99). Most PPMs that developed into 2-DTC had a lower risk of DTC-specific death than 1-DTC, but many PPMs had a higher risk of cancer-specific death. Conclusion Given the characteristics and outcomes of 2-DTC, aggressive treatment for 2-DTC, particularly for PPM with a high mortality risk, may not be advisable.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
林夕完成签到,获得积分10
刚刚
llll发布了新的文献求助30
2秒前
橘猫完成签到 ,获得积分10
3秒前
3秒前
柔弱的自行车完成签到,获得积分10
3秒前
5秒前
研友_VZG7GZ应助xieyuanxing采纳,获得10
5秒前
zhangkele完成签到,获得积分10
5秒前
受伤的随阴完成签到,获得积分10
5秒前
6秒前
yjzzz完成签到,获得积分10
6秒前
沉默的涔完成签到 ,获得积分10
6秒前
岱山完成签到,获得积分10
6秒前
领导范儿应助小李采纳,获得30
7秒前
olivia完成签到,获得积分10
7秒前
8秒前
共享精神应助小麻花采纳,获得10
9秒前
内向翰发布了新的文献求助10
10秒前
今天摸了吗完成签到,获得积分10
10秒前
硬币完成签到,获得积分10
11秒前
阳光代芙完成签到,获得积分20
12秒前
橘猫发布了新的文献求助10
13秒前
13秒前
Ming发布了新的文献求助10
15秒前
15秒前
Ferris完成签到,获得积分10
16秒前
17秒前
墨月完成签到,获得积分10
17秒前
18秒前
科研通AI6.1应助Roni采纳,获得100
18秒前
GL发布了新的文献求助10
18秒前
18秒前
zzz发布了新的文献求助10
19秒前
传奇3应助liyang采纳,获得10
19秒前
小麻花完成签到,获得积分10
21秒前
王翔飞完成签到 ,获得积分10
21秒前
任一发布了新的文献求助10
22秒前
星弟发布了新的文献求助10
22秒前
23秒前
xieyuanxing发布了新的文献求助10
23秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 2000
Digital Twins of Advanced Materials Processing 2000
Social Cognition: Understanding People and Events 1200
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6036841
求助须知:如何正确求助?哪些是违规求助? 7756755
关于积分的说明 16215982
捐赠科研通 5182881
什么是DOI,文献DOI怎么找? 2773678
邀请新用户注册赠送积分活动 1756929
关于科研通互助平台的介绍 1641299